W. TermrungruanglertA. P. KudelkaS. PiamsomboonC. L. EdwardsC. F. VerschraegenE. LoyerJ. J. KavanaghChulalongkorn UniversityUniversity of Texas MD Anderson Cancer CenterMahidol UniversityBox 392018-07-042018-07-041996-12-21European Journal of Gynaecological Oncology. Vol.17, No.6 (1996), 493-496039229362-s2.0-0029827414https://repository.li.mahidol.ac.th/handle/123456789/17649We report the case of a patient with recurrent squamous cell carcinoma of the cervix, that metastasized to the paraaortic and supraclavicular lymph nodes and the lungs after primary radiotherapy for stage IIB. The tumor was refractory to multiple drug regimens. A combination of paclitaxel (135 mg/m2intravenous infusion over 24) hours and carboplatin with a target area under the curve of 7.5 mg.min/mL were then administered and repeated every 4 weeks. The patient tolerated the chemotherapy well with myeloprotection from granulocyte colony-stimulating factor and the disease went into remission. Thus, the combination of paclitaxel and car boplatin may have antirumor activity in advanced or recurrent squamous cell carcinoma of the cervix.Mahidol UniversityMedicineArticleSCOPUS